Noninvasive assessment of characteristics of novel anti-HER2

Por um escritor misterioso

Descrição

Noninvasive assessment of characteristics of novel anti-HER2
IJMS, Free Full-Text
Noninvasive assessment of characteristics of novel anti-HER2
Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model
Noninvasive assessment of characteristics of novel anti-HER2
New Approach May Help Predict HER2+ Tumor Response to Treatment – Consult QD
Noninvasive assessment of characteristics of novel anti-HER2
Hierarchically Structured Molecularly Imprinted Nanotransducers for Truncated HER2-Targeted Photodynamic Therapy of Therapeutic Antibody-Resistant Breast Cancer
Noninvasive assessment of characteristics of novel anti-HER2
Combination Therapies for Advanced Biliary Tract Cancer
Noninvasive assessment of characteristics of novel anti-HER2
Clinical and translational relevance of intratumor heterogeneity: Trends in Cancer
Noninvasive assessment of characteristics of novel anti-HER2
Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics
Noninvasive assessment of characteristics of novel anti-HER2
Frontiers Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
Noninvasive assessment of characteristics of novel anti-HER2
Two- and three-component anti-HER2 vaccines that contain the MFCH401
Noninvasive assessment of characteristics of novel anti-HER2
Cancers, Free Full-Text
Noninvasive assessment of characteristics of novel anti-HER2
Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET
Noninvasive assessment of characteristics of novel anti-HER2
Herceptin-Conjugated DOX-Fe3O4/P(NIPAM-AA-MAPEG) Nanogel System for HER2-Targeted Breast Cancer Treatment and Magnetic Resonance Imaging
Noninvasive assessment of characteristics of novel anti-HER2
Frontiers Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer
Noninvasive assessment of characteristics of novel anti-HER2
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations - eClinicalMedicine
de por adulto (o preço varia de acordo com o tamanho do grupo)